Transcarent, a digital platform focused on the self-insured employer market, announced it secured a $126 million Series D investment. The funds bring the unicorn company's total raise to $450 million and valuation to $2.2 billion.
General Catalyst and 7wireVentures led the round, with participation from new investors Memorial Hermann Health System and Geodesic Capital.
Former investors Human...
Transcarent, a digital platform focused on the self-insured employer market, and ViewFi, a tech-enabled virtual orthopedic and rehabilitation platform, are partnering to deliver virtual orthopedic and musculoskeletal care to patients through Transcarent's Consult Solution.
ViewFi, cofounded by U.S. tennis champion Andy Roddick, offers virtual care, one-on-one exams and at-home appointments...
There was a massive influx of capital provided to digital health companies in 2021, but there's since been a contraction in the public market, with digital health funding decreasing.
Still, with the increased investments seen last year, companies' valuations rose and many gained unicorn status, a term given to privately held companies valued at a billion dollars or more.
But were companies...
Transcarent, a healthcare platform for self-insured employers, scored a whopping $200 million in Series C funding. Kinnevik and Human Capital led the round, with participation from Ally Bridge Group, General Catalyst, 7wireVentures and existing Transcarent investors.
Led by Livongo vet Glen Tullman, the company emerged out of stealth in March with $40 million in funding. Over the summer, the...
Digital health vet Glen Tullman has taken on some of the biggest challenges in healthcare, from chronic conditions to electronic health records. After selling Livongo to Teladoc in 2020 for a whopping $18.5 billion, Tullman has focused his efforts on the insurance space with the launch of Transcarent, a healthcare platform for self-insured employers.
The company, which emerged out of stealth in...
*/
Focus on Innovation
In September, we take a deep dive into the cutting-edge development and disruption of healthcare innovation.
Livongo Health, the diabetes management company launched last fall by former Allscripts CEO Glen Tullman, has raised $20 million in second-round funding. Kleiner Perkins Caufield & Byers (KPCB) and DFJ Venture contributed to the round, as did previous investor General Catalyst Partners.
"With thousands of people now using Livongo for Diabetes, it's clear that the best way for people to...
There’s no question that funding for digital health companies is high -- a recent report from Accenture predicted funding for digital health startups will reach $6.5 billion by the end of 2017, up from $3.5 billion in 2014. But that doesn’t mean it’s smooth sailing for digital health investors or the companies seeking funding. At a Tuesday session at Health 2.0 in Santa Clara, California, a panel...
Glen Tullman, the former Allscripts CEO who left the company at the end of 2012 by mutual agreement, is back in the health field. His newest venture, Livongo, launched from the stage of TechCrunch's Disrupt conference in San Francisco and has already raised a $10 million funding round from General Catalyst Partners.
"Our plan is to use the experience gained in Silicon Valley on consumer ...
Mountain View, California-based TrueVault has raised $2.5 million in seed funding according to TechCrunch, from a range of big name investors including FundersClub, Paul Buchheit, ScoreBig founder Joel Milne, and an LLC that includes Andreessen Horowitz, General Catalyst, Maverick, and Khosla Ventures, and Immunity Project founders Reid Rubsamen, Naveen Jain, and Ian Cinnamon.
The company, which...
